81 related articles for article (PubMed ID: 11427501)
1. Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter.
Pifl C; Zezula J; Spittler A; Kattinger A; Reither H; Caron MG; Hornykiewicz O
FASEB J; 2001 Jul; 15(9):1607-9. PubMed ID: 11427501
[No Abstract] [Full Text] [Related]
2. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.
Paris I; Martinez-Alvarado P; Perez-Pastene C; Vieira MN; Olea-Azar C; Raisman-Vozari R; Cardenas S; Graumann R; Caviedes P; Segura-Aguilar J
J Neurochem; 2005 Mar; 92(5):1021-32. PubMed ID: 15715653
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-induced apoptosis in human neuronal cells: inhibition by nucleic acids antisense to the dopamine transporter.
Simantov R; Blinder E; Ratovitski T; Tauber M; Gabbay M; Porat S
Neuroscience; 1996 Sep; 74(1):39-50. PubMed ID: 8843076
[TBL] [Abstract][Full Text] [Related]
4. Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system.
Takahashi T; Deng Y; Maruyama W; Dostert P; Kawai M; Naoi M
J Neural Transm Gen Sect; 1994; 98(2):107-18. PubMed ID: 7734108
[TBL] [Abstract][Full Text] [Related]
5. Dopamine uptake by mouse neuroblastoma N1E-115 cells stably expressing human dopamine transporter is differentially inhibited by anti-idiotypic ab2beta antibodies mimicking the configuration of cocaine.
Ho M; Segre M
Brain Res; 2000 Jul; 872(1-2):231-5. PubMed ID: 10924700
[TBL] [Abstract][Full Text] [Related]
6. Cellular effects of dopamine--beyond oxidative mechanisms.
Pifl C; Kattinger A; Reither H; Hornykiewicz O
Parkinsonism Relat Disord; 2002 Sep; 8(6):433-7. PubMed ID: 12217632
[TBL] [Abstract][Full Text] [Related]
7. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter.
Pifl C; Hornykiewicz O; Giros B; Caron MG
J Pharmacol Exp Ther; 1996 Jun; 277(3):1437-43. PubMed ID: 8667208
[TBL] [Abstract][Full Text] [Related]
8. Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro.
Koutsilieri E; Götz ME; Sopper S; Sauer U; Demuth M; ter Meulen V; Riederer P
J Neurovirol; 1997 Oct; 3(5):342-9. PubMed ID: 9372455
[TBL] [Abstract][Full Text] [Related]
9. 3 alpha-(4'-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters: novel ligands with high affinity and selectivity at the dopamine transporter.
Holmquist CR; Keverline-Frantz KI; Abraham P; Boja JW; Kuhar MJ; Carroll FI
J Med Chem; 1996 Oct; 39(21):4139-41. PubMed ID: 8863789
[No Abstract] [Full Text] [Related]
10. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic and adrenergic toxicities on SK-N-MC human neuroblastoma cells are mediated through G protein signaling and oxidative stress.
Chan AS; Ng LW; Poon LS; Chan WW; Wong YH
Apoptosis; 2007 Jan; 12(1):167-79. PubMed ID: 17136323
[TBL] [Abstract][Full Text] [Related]
12. The dopamine transporter. The cloned target site of parkinsonism-inducing toxins and of drugs of abuse.
Pifl C; Giros B; Caron MG
Adv Neurol; 1996; 69():235-8. PubMed ID: 8615133
[No Abstract] [Full Text] [Related]
13. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants.
Buck KJ; Amara SG
Mol Pharmacol; 1995 Dec; 48(6):1030-7. PubMed ID: 8848002
[TBL] [Abstract][Full Text] [Related]
14. Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.
Lee FJ; Liu F; Pristupa ZB; Niznik HB
FASEB J; 2001 Apr; 15(6):916-26. PubMed ID: 11292651
[TBL] [Abstract][Full Text] [Related]
15. The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA-induced toxicity.
Manáková S; Puttonen KA; Raasmaja A; Männistö PT
Toxicol Lett; 2004 Dec; 154(1-2):117-23. PubMed ID: 15475185
[TBL] [Abstract][Full Text] [Related]
16. 6-fluorodopamine selectively destroys neuroblastoma cells expressing the noradrenaline transporter.
Seitz G; Bruchelt G; Kuci Z; Roginsky VA; Wolburg H; Stegmann HB; Niethammer D
Med Pediatr Oncol; 2000 Dec; 35(6):612-5. PubMed ID: 11107129
[TBL] [Abstract][Full Text] [Related]
17. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium.
Buck KJ; Amara SG
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12584-8. PubMed ID: 7809082
[TBL] [Abstract][Full Text] [Related]
18. Catecholamine reuptake and storage. Overview.
Bönisch H; Eiden L
Adv Pharmacol; 1998; 42():149-64. PubMed ID: 9327868
[No Abstract] [Full Text] [Related]
19. Inactivation of the dopamine transporter reveals essential roles of dopamine in the control of locomotion, psychostimulant response, and pituitary function.
Fumagalli F; Jones S; Bossé R; Jaber M; Giros B; Missale C; Wightman RM; Caron MG
Adv Pharmacol; 1998; 42():179-82. PubMed ID: 9327873
[No Abstract] [Full Text] [Related]
20. [Aminetransporters].
Shimada S
Tanpakushitsu Kakusan Koso; 1997 Feb; 42(3 Suppl):244-52. PubMed ID: 9162958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
